semaglutide plus b12 with Methylcobalamin (B12) Injection Semaglutide with B12: A Dual

Neurological Conditions: Conditions like Parkinsons or MS can play a role

As a GLP-1 receptor agonist, semaglutide presents an exciting opportunity for patients seeking to manage their type 2 diabetes and achieve weight loss goals

Rare but serious side effects include seizures and hypertension

If GLP-1 receptor agonism, and by extension the dual and triple agonists, and possibly the cleaner endogenous peptides like BRP, operates as a class of geroscience interventions rather than a class of weight-loss drugs that happen to have nice cardiovascular side benefits, then the population for whom these molecules might matter is much larger than the population that currently qualifies for them under any obesity- or diabetes-based prescribing guideline